Intuitive Surgical, Inc. (ISRG)

NASDAQ: ISRG · IEX Real-Time Price · USD
-0.11 (-0.05%)
At close: Aug 15, 2022 4:00 PM
-0.06 (-0.03%)
After-hours: Aug 15, 2022 7:59 PM EDT
Market Cap 85.09B
Revenue (ttm) 5.96B
Net Income (ttm) 1.43B
Shares Out 357.11M
EPS (ttm) 3.95
PE Ratio 60.32
Forward PE 50.51
Dividend n/a
Ex-Dividend Date n/a
Volume 1,347,944
Open 237.03
Previous Close 238.37
Day's Range 235.81 - 239.64
52-Week Range 186.83 - 369.69
Beta 1.29
Analysts Buy
Price Target 260.30 (+9.3%)
Earnings Date Jul 21, 2022

About ISRG

Intuitive Surgical, Inc. develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System to enable complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung. It also provides a suite of stapling, energy, and core i... [Read more...]

Industry Health Care Equipment & Supplies
IPO Date Jun 13, 2000
CEO Gary Guthart
Employees 9,793
Stock Exchange NASDAQ
Ticker Symbol ISRG
Full Company Profile

Financial Performance

In 2021, ISRG's revenue was $5.71 billion, an increase of 31.01% compared to the previous year's $4.36 billion. Earnings were $1.70 billion, an increase of 60.72%.

Financial Statements

Analyst Forecast

According to 27 analysts, the average rating for ISRG stock is "Buy." The 12-month stock price forecast is 260.3, which is an increase of 9.25% from the latest price.

Price Target
(9.25% upside)
Analyst Consensus: Buy
Stock Forecasts


Nasdaq Bear Market: 5 Brilliant Growth Stocks You'll Regret Not Buying on the Dip

These innovative growth stocks are ripe for the picking following a 34% peak plunge in the Nasdaq Composite.


5 Stocks I'll Almost Certainly Still Own in 2030

These stocks share one important common denominator: great long-term growth prospects.


Buying Shares of These 2 Monster Stocks on the Dip Could Be a Genius Move

They're the undisputed leaders of their markets.

Other symbols: ILMN

2 Trends That Suggest Healthcare Stocks Can Beat the Bear Market

As a whole, healthcare has done better than the broader market this year.

Other symbols: JNJWBA

3 Growth Stocks Down 25% to 71% to Buy in August

The future still looks bright for these beaten-down stocks.

Other symbols: AMZNPYPL

3 Things the Smartest Investors Do When the Market Is Crazy

They stay focused on the long term and act accordingly.

Other symbols: COST

Bear Market Investing: 3 Reasons to Buy Stocks Now

You may thank yourself a few years from now.

Other symbols: KONKE

Is Intuitive Surgical Stock a Buy Now?

Second-quarter 2022 financial results weren't as good as expected -- but were still solid.

Should You Buy This Industry-Leading Stock on the Dip Now?

For long-term investors, the answer is crystal clear.

7 Undervalued Biotech Stocks to Buy Before They Boom

Despite recession fears, biological sciences will never go out of style, thus benefitting these undervalued biotech stocks to buy. The post 7 Undervalued Biotech Stocks to Buy Before They Boom appeared ...

Should You Worry About This 1 Number From Intuitive Surgical?

It's important to look at the long-term picture.

Intuitive Surgical Stock: Here's the Good News Investors are Ignoring

This leader's woes won't last forever.

Stock Market Slumps As Major Stock Indexes Hit Key Resistance; Wall Street Braces For Big Week Of Earnings

The stock market rally came under pressure Friday as the major stock indexes ran into some key resistance levels. The post Stock Market Slumps As Major Stock Indexes Hit Key Resistance; Wall Street Brac...

Other symbols: SNAPSTX

Why Intuitive Surgical Stock Looks Sickly Today

Intuitive missed on the top and bottom lines, and its stock is expensive.

Why Is Intuitive Surgical (ISRG) Stock Down 7% Today?

Intuitive Surgical (ISRG) stock is slipping on Friday after the medical robotics company reported results for the second quarter of 2022. The post Why Is Intuitive Surgical (ISRG) Stock Down 7% Today?

Intuitive Surgical (ISRG) Q2 Earnings Miss, Procedures Recover

Intuitive Surgical's (ISRG) second-quarter results reflect health demand for procedures despite the resurgence of COVID-19 infections.

Intuitive Surgical Stock Is Tanking. But Analysts Like the Long-Term Story.

The company said it was difficult to match some customer orders by the end of the second quarter because of delays in semiconductor components.

ISRG Stock Dives: How Covid Took A Swipe At Robotic Surgery Giant Intuitive Surgical

Intuitive Surgical earnings and sales missed Q2 views as Covid continued to have an impact on the robotic surgery giant. ISRG stock plunged.

Intuitive Surgical, Inc. (ISRG) Q2 Earnings and Revenues Miss Estimates

Intuitive Surgical, Inc. (ISRG) delivered earnings and revenue surprises of -1.72% and 2.53%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?

Intuitive Surgical stock falls more than 13% after Q2 results fall short

Shares of Intuitive Surgical dropped more than 13% in the extended session Thursday after the maker of surgical robotic systems reported second-quarter results below Wall Street expectations and said th...

Intuitive Surgical Stock Plunges After Q2 Results Miss Street Expectation

Intuitive Surgical, Inc. (NASDAQ: ISRG) reported second-quarter revenue growth of 4% year-over-year to $1.52 billion, +6% on a constant currency basis, missing the consensus of $1.56 billion. The gross ...

Intuitive Announces Second Quarter Earnings

SUNNYVALE, Calif., July 21, 2022 (GLOBE NEWSWIRE) -- Intuitive (the “Company”) (Nasdaq: ISRG), a global technology leader in minimally invasive care and the pioneer of robotic-assisted surgery, today an...

Is a Surprise Coming for Intuitive Surgical (ISRG) This Earnings Season?

Intuitive Surgical (ISRG) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.

J&J Medtech Outlook Boosts Shares of Stryker, Biomet and Intuitive

While Johnson & Johnson's ( JNJ , Financial) Medtech sales were lower in the second quarter, revenue from hips and knee replacements was on target or above, a development that could spill over into segm...

Other symbols: JNJSYKZBH

3 Healthcare Stocks That Could Help Set You Up for Life

These players are trading at bargain prices today.

Other symbols: ABTMRNA